Home > PB Ratio > NGL FINECHEM

NGL FINECHEM
PB (Price/Book ) Ratio

The Current P/B Ratio of NGL FINECHEM is 2.64.

Share Price ₹1,190.0Jul 02,2025
Market Cap ₹737.8 Cr
Book Value₹279.6 CrMar2025 - Consolidated Results
Price/Book 2.64xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results
NGL FINECHEM is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of NGL FINECHEM

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of NGL FINECHEM is calculated as :

Current Market Cap [ ₹737.8 Cr] as on Jul 02,2025

(/) Book Value [ ₹279.6 Cr] based on Mar2025 - Consolidated Results

(=) P/B Ratio [ 2.64x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for NGL FINECHEM , the investors are currently willing to pay '2.64 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of NGL FINECHEM !

The chart below summarizes the trend in P/B Ratio of NGL FINECHEM over the last five years.

Historical PB (Price/Book ) ratio chart of NGL FINECHEM


PB Ratio Performance Analysis for NGL FINECHEM

- NGL FINECHEM 's latest p/b ratio is 2.64x.

- NGL FINECHEM 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 4.38x.

- NGL FINECHEM 's operated at median p/b ratio of 4.92x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NGL FINECHEM 's p/b ratio peaked in Mar2021 at 6.13x.

- NGL FINECHEM 's p/b ratio hit its five-year low in Mar2020 of 1.58x.


How does NGL FINECHEM 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
NGL FINECHEM 279.612.64737.8
SUN PHARMACEUTICAL INDUSTRIES LTD72,218.005.57402,584.0
DIVIS LABORATORIES LTD14,969.0012.17182,147.0
CIPLA LTD31,079.303.89120,941.0
TORRENT PHARMACEUTICALS LTD7,591.2314.93113,325.0
DR REDDYS LABORATORIES LTD33,404.903.18106,138.0
MANKIND PHARMA LTD14,332.406.8798,491.5
ZYDUS LIFESCIENCES LTD23,953.104.18100,176.0
LUPIN LTD17,203.505.2289,863.5
AUROBINDO PHARMA LTD32,653.302.0667,242.3
ABBOTT INDIA LTD4,233.1517.7675,200.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs NGL FINECHEM 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.06x
Max industry PB 17.76x
Median industry PB 5.22x
Average industry PB 7.13x



You may also like the below Video Courses